Приказ основних података о документу

dc.creatorBogavac-Stanojević, Nataša
dc.creatorPetrova, Guenka
dc.creatorJelić-Ivanović, Zorana
dc.creatorMemon, Lidija
dc.creatorSpasić, Slavica
dc.date.accessioned2019-09-02T11:09:02Z
dc.date.available2019-09-02T11:09:02Z
dc.date.issued2007
dc.identifier.issn0009-9120
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/903
dc.description.abstractObjectives: The aim of our study was to determine the cost-effectiveness of coronary artery disease (CAD) diagnostic parameters in a clinical laboratory setting. Design and methods: The effectiveness of apolipoproteins, lipoproteins and high sensitivity C-reactive protein (hs-CRP) supplementary to Framingham scoring data within a CAD risk assessment procedure was established in 221 CAD patients and 289 controls. The total costs of diagnostic procedures were calculated and incremental cost-effectiveness analysis was applied. Results: A diagnostic strategy employing Framingham calculation followed by apolipoprotein A-I (apoA-I) had the lowest cost per additional successfully diagnosed patient than the same strategy followed by hs-CRP in the low (2.63 vs. 24.47 euros) and intermediate-risk groups (2.96 vs. 122.85 euros). in the high-risk group the diagnostic strategy employing apoA-I saved 9.14 euros in comparison to the strategy employing hs-CRP. Conclusion: Cost-effectiveness analysis of different diagnostic markers results in improved identification of at-risk patients at a lower health cost for society.en
dc.publisherPergamon-Elsevier Science Ltd, Oxford
dc.relationinfo:eu-repo/grantAgreement/MESTD/MPN2006-2010/145036/RS//
dc.rightsrestrictedAccess
dc.sourceClinical Biochemistry
dc.subjectcost-effectivenessen
dc.subjectcoronary artery diseaseen
dc.subjectlipidsen
dc.subjectlipoproteinsen
dc.subjectApolipoproteinsen
dc.subjecths-CRPen
dc.titleCost-effectiveness analysis in diagnosis of coronary artery disease: Choice of laboratory markersen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractСпасић, Славица; Богавац-Станојевић, Наташа; Мемон, Лидија; Јелић-Ивановић, Зорана; Петрова, Гуенка;
dc.citation.volume40
dc.citation.issue16-17
dc.citation.spage1180
dc.citation.epage1187
dc.citation.other40(16-17): 1180-1187
dc.citation.rankM22
dc.identifier.wos000250605200002
dc.identifier.doi10.1016/j.clinbiochem.2007.07.004
dc.identifier.pmid17869234
dc.identifier.scopus2-s2.0-35248865222
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу